Show simple item record

dc.contributor.authorMoreira-Soto, Andres
dc.contributor.authorArguedas, Mauricio
dc.contributor.authorBrenes, Hebleen
dc.contributor.authorBuján, Willem
dc.contributor.authorCorrales-Aguilar, Eugenia
dc.contributor.authorDíaz, Cecilia
dc.contributor.authorEcheverri, Ann
dc.contributor.authorFlores-Díaz, Marietta
dc.contributor.authorGómez, Aarón
dc.contributor.authorHernández, Andrés
dc.contributor.authorHerrera, María
dc.contributor.authorLeón, Guillermo
dc.contributor.authorMacaya, Román
dc.contributor.authorKühne, Arne
dc.contributor.authorMolina-Mora, José Arturo
dc.contributor.authorMora, Javier
dc.contributor.authorSanabria, Alfredo
dc.contributor.authorSánchez, Andrés
dc.contributor.authorSánchez, Laura
dc.contributor.authorSegura, Álvaro
dc.contributor.authorSegura, Eduardo
dc.contributor.authorSolano, Daniela
dc.contributor.authorSoto, Claudio
dc.contributor.authorStynoski, Jennifer L
dc.contributor.authorVargas, Mariángela
dc.contributor.authorVillalta, Mauren
dc.contributor.authorReusken, Chantal B E M
dc.contributor.authorDrosten, Christian
dc.contributor.authorGutiérrez, José María
dc.contributor.authorAlape-Girón, Alberto
dc.contributor.authorDrexler, Jan Felix
dc.date.accessioned2021-10-12T20:08:39Z
dc.date.available2021-10-12T20:08:39Z
dc.date.issued2021-09-06
dc.identifier.issn2296-858X
dc.identifier.pmid34552949
dc.identifier.doi10.3389/fmed.2021.735853
dc.identifier.urihttp://hdl.handle.net/10029/625318
dc.language.isoenen_US
dc.rightsCopyright © 2021 Moreira-Soto, Arguedas, Brenes, Buján, Corrales-Aguilar, Díaz, Echeverri, Flores-Díaz, Gómez, Hernández, Herrera, León, Macaya, Kühne, Molina-Mora, Mora, Sanabria, Sánchez, Sánchez, Segura, Segura, Solano, Soto, Stynoski, Vargas, Villalta, Reusken, Drosten, Gutiérrez, Alape-Girón and Drexler.
dc.subjectCOVID-19en_US
dc.subjectPRNT titers 50en_US
dc.subjectSARS-CoV-2en_US
dc.subjectequine antibodiesen_US
dc.subjectneutralization testen_US
dc.subjecttherapyen_US
dc.subjectvariant of concernen_US
dc.titleHigh Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern.en_US
dc.typeArticleen_US
dc.identifier.journalFront Med 2021; 8:735853en_US
dc.source.journaltitleFrontiers in medicine
dc.source.volume8
dc.source.beginpage735853
dc.source.endpage
dc.source.countrySwitzerland


This item appears in the following Collection(s)

Show simple item record